Hypovitaminosis D is Associated with Greater Body Mass Index and Disease Activity in Pediatric Systemic Lupus Erythematosus

Journal of Pediatrics

Volumn 155, Issue 2, 2009, Pages 260-265

  Wright, Tracey B ^a,c   Shults, Justine ^c   Leonard, Mary B ^b,c   Zemel, Babette S ^b,c   Burnham, Jon M ^b,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; PARATHYROID HORMONE;

ADOLESCENT; ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS; VITAMIN D DEFICIENCY;

ADOLESCENT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANTIBODIES, MONOCLONAL; BODY MASS INDEX; CALCITRIOL; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNOLOGIC FACTORS; LINEAR MODELS; LUNG DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MUCOUS MEMBRANE; PARATHYROID HORMONE; SEVERITY OF ILLNESS INDEX; SKIN ULCER; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 67651085514     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2009.02.033     Document Type: Article

References (48)

1. Holick M.F. Vitamin D deficiency. N Engl J Med 357 (2007) 266-281
2. Giovannucci E. Strengths and limitations of current epidemiologic studies: vitamin D as a modifier of colon and prostate cancer risk. Nutr Rev 65 (2007) S77-S79
3. Munger K.L., Levin L.I., Hollis B.W., Howard N.S., and Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296 (2006) 2832-2838
4. Nnoaham K.E., and Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 37 (2008) 113-119
5. Wang T.J., Pencina M.J., Booth S.L., Jacques P.F., Ingelsson E., Lanier K., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 117 (2008) 503-511
6. Rockell J.E., Green T.J., Skeaff C.M., Whiting S.J., Taylor R.W., Williams S.M., et al. Season and ethnicity are determinants of serum 25-hydroxyvitamin D concentrations in New Zealand children aged 5-14 y. J Nutr 135 (2005) 2602-2608
7. Weng F.L., Shults J., Leonard M.B., Stallings V.A., and Zemel B.S. Risk factors for low serum 25-hydroxyvitamin D concentrations in otherwise healthy children and adolescents. Am J Clin Nutr 86 (2007) 150-158
8. Wortsman J., Matsuoka L.Y., Chen T.C., Lu Z., and Holick M.F. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72 (2000) 690-693
9. Hiraki L.T., Benseler S.M., Tyrrell P.N., Hebert D., Harvey E., and Silverman E.D. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study. J Pediatr 152 (2008) 550-556
10. Compeyrot-Lacassagne S., Tyrrell P.N., Atenafu E., Doria A.S., Stephens D., Gilday D., et al. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus. Arthritis Rheum 56 (2007) 1966-1973
11. Posadas-Romero C., Torres-Tamayo M., Zamora-Gonzalez J., Aguilar-Herrera B.E., Posadas-Sanchez R., Cardoso-Saldana G., et al. High insulin levels and increased low-density lipoprotein oxidizability in pediatric patients with systemic lupus erythematosus. Arthritis Rheum 50 (2004) 160-165
12. Gauzzi M.C., Purificato C., Donato K., Jin Y., Wang L., Daniel K.C., et al. Suppressive effect of 1alpha,25-dihydroxyvitamin D3 on type I IFN-mediated monocyte differentiation into dendritic cells: impairment of functional activities and chemotaxis. J Immunol 174 (2005) 270-276
13. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40 (1997) 1725
14. Rovner A.J., Stallings V.A., Kawchak D.A., Schall J.I., Ohene-Frempong K., and Zemel B.S. High risk of vitamin D deficiency in children with sickle cell disease. J Am Diet Assoc 108 (2008) 1512-1516
15. Rovner A.J., Stallings V.A., Schall J.I., Leonard M.B., and Zemel B.S. Vitamin D insufficiency in children, adolescents, and young adults with cystic fibrosis despite routine oral supplementation. Am J Clin Nutr 86 (2007) 1694-1699
16. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., and Chang C.H. Derivation of the SLEDAI: a disease activity index for lupus patients: the Committee on Prognosis Studies in SLE. Arthritis Rheum 35 (1992) 630-640
17. Schwartz M.M. The pathology of lupus nephritis. Semin Nephrol 27 (2007) 22-34
18. Ogden C.L., Kuczmarski R.J., Flegal K.M., Mei Z., Guo S., Wei R., et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 109 (2002) 45-60
19. Morris N.N., and Udry J.R. Validation of a self-administered instrument to assess stage of adolescent development. J Youth Adolesc (1980) 271-280
20. DeLuca H.F. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 80 (2004) 1689S-1696S
21. Hollis B.W., Kamerud J.Q., Selvaag S.R., Lorenz J.D., and Napoli J.L. Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer. Clinical Chemistry 39 (1993) 529-533
22. Hollis B.W., Kamerud J.Q., Kurkowski A., Beaulieu J., and Napoli J.L. Quantification of circulating 1,25-dihydroxyvitamin D by radioimmunoassay with 125I-labeled tracer. Clin Chem 42 (1996) 586-592
23. Bischoff-Ferrari H.A., Giovannucci E., Willett W.C., Dietrich T., and Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84 (2006) 18-28
24. Ellis K.J. Human body composition: in vivo methods. Physiol Rev 80 (2000) 649-680
25. Gordon C.M., DePeter K.C., Feldman H.A., Grace E., and Emans S.J. Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med 158 (2004) 531-537
26. Alemzadeh R., Kichler J., Babar G., and Calhoun M. Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism 57 (2008) 183-191
27. Snijder M.B., van Dam R.M., Visser M., Deeg D.J., Dekker J.M., Bouter L.M., et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab 90 (2005) 4119-4123
28. Thudi A., Yin S., Wandstrat A.E., Li Q.Z., and Olsen N.J. Vitamin D levels and disease status in Texas patients with systemic lupus erythematosus. Am J Med Sci 335 (2008) 99-104
29. Borba V.Z., Vieira J.G., Kasamatsu T., Radominski S.C., Sato E.I., and Lazaretti-Castro M. Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporos Int (2008)
30. Kamen D.L., Cooper G.S., Bouali H., Shaftman S.R., Hollis B.W., and Gilkeson G.S. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 5 (2006) 114-117
31. Ruiz-Irastorza G., Egurbide M.V., Olivares N., Martinez-Berriotxoa A., and Aguirre C. Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology (Oxford) 47 (2008) 920-923
32. Chen S., Sims G.P., Chen X.X., Gu Y.Y., Chen S., and Lipsky P.E. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 179 (2007) 1634-1647
33. Holick M.F., Chen T.C., Lu Z., and Sauter E. Vitamin D and skin physiology: a D-lightful story. J Bone Miner Res 22 Suppl 2 (2007) V28-V33
34. Rahman A., and Isenberg D.A. Systemic lupus erythematosus. N Engl J Med 358 (2008) 929-939
35. Carvalho J.F., Blank M., Kiss E., Tarr T., Amital H., and Shoenfeld Y. Anti-vitamin D, vitamin D in SLE: preliminary results. Ann N Y Acad Sci 1109 (2007) 550-557
36. Burnham J.M., Shults J., Semeao E., Foster B.J., Zemel B.S., Stallings V.A., et al. Body-composition alterations consistent with cachexia in children and young adults with Crohn disease. Am J Clin Nutr 82 (2005) 413-420
37. Chun H.Y., Chung J.W., Kim H.A., Yun J.M., Jeon J.Y., Ye Y.M., et al. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus. J Clin Immunol 27 (2007) 461-466
38. Gazarian M., Laxer R.M., Kooh S.W., and Silverman E.D. Hypoparathyroidism associated with systemic lupus erythematosus. J Rheumatol 22 (1995) 2156-2158
39. Gavalas N.G., Kemp E.H., Krohn K.J., Brown E.M., Watson P.F., and Weetman A.P. The calcium-sensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab 92 (2007) 2107-2114
40. Li Y., Song Y.H., Rais N., Connor E., Schatz D., Muir A., et al. Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism. J Clin Invest 97 (1996) 910-914
41. Bonadonna S., Burattin A., Nuzzo M., Bugari G., Rosei E.A., Valle D., et al. Chronic glucocorticoid treatment alters spontaneous pulsatile parathyroid hormone secretory dynamics in human subjects. Eur J Endocrinol 152 (2005) 199-205
42. Adams J.S., Diz M.M., and Sharma O.P. Effective reduction in the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia with short-course chloroquine therapy. Ann Intern Med 111 (1989) 437-438
43. Bultink I.E., Lems W.F., Kostense P.J., Dijkmans B.A., and Voskuyl A.E. Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 52 (2005) 2044-2050
44. Cheng S., Tylavsky F., Kroger H., Karkkainen M., Lyytikainen A., Koistinen A., et al. Association of low 25-hydroxyvitamin D concentrations with elevated parathyroid hormone concentrations and low cortical bone density in early pubertal and prepubertal Finnish girls. Am J Clin Nutr 78 (2003) 485-492
45. Norman A.W. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 88 (2008) 491S-499S
46. Lemire J.M., Ince A., and Takashima M. 1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice. Autoimmunity 12 (1992) 143-148
47. Blanco P., Palucka A.K., Gill M., Pascual V., and Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 294 (2001) 1540-1543
48. Griffin M.D., Lutz W., Phan V.A., Bachman L.A., McKean D.J., and Kumar R. Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci U S A 98 (2001) 6800-6805